专利摘要:
The present invention relates to the use of glycogen of marine origin for the manufacture of topical compositions to minimize biological alterations of the skin, in particular alterations in biological parameters, due to electromagnetic radiation emitted by electronic devices, such as mobile phones, tablets or computers portable, as well as a procedure to minimize biological alterations of the skin, in particular alterations in biological parameters, due to electromagnetic radiation emitted by electronic devices, such as mobile phones, tablets or laptops, the method comprising the topical application of a composition which includes glycogen of marine origin. (Machine-translation by Google Translate, not legally binding)
公开号:ES2633129A1
申请号:ES201630326
申请日:2016-03-18
公开日:2017-09-19
发明作者:Alberto THIEBAUT ESTRADA;Cristina THIEBAUT ESTRADA;Lorena SÁNCHEZ CUENDIAS
申请人:Ind Asociadas S L;Industrias Asociadas SL;
IPC主号:
专利说明:

image 1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image12
image13
权利要求:
Claims (1)
[1]
image 1
类似技术:
公开号 | 公开日 | 专利标题
EA201791563A1|2018-01-31|SUBSTITUTED NUCLEOSIDE DERIVATIVES, USEFUL AS AN AGENT AGAINST CANCER
CL2016000807A1|2016-07-08|Amino heteroaryl benzamides as kinase inhibitors.
BR112019007369A2|2019-07-16|anti-lag-3 antibodies and methods of use
CL2015002394A1|2015-12-28|Histone Demethylase Inhibitors
CL2015000094A1|2015-06-19|Compounds derived from imidazotriazincarbonitriles, protein kinase inhibitors; pharmaceutical composition that includes them; and its use to treat cancer, psoriasis and rheumatoid arthritis.
TR201815172T4|2018-11-21|Glucagon / GLP-1 agonists for the treatment of obesity.
EA201591961A1|2016-06-30|ACC INHIBITORS AND THEIR APPLICATION
CL2012003415A1|2013-08-09|Compounds derived from 2-oxo-piperidine and 1,1-dioxide-thiazine, mdm2 inhibitors; pharmaceutical composition that includes them; and its use for the treatment of cancer.
EA201591960A1|2016-06-30|ACC INHIBITORS AND THEIR APPLICATION
BR112012016740A2|2017-06-13|portable computing device
TR201816069T4|2018-11-21|Arilkinazol parts.
EA201792096A2|2018-01-31|RAPPγ AGONISTS FOR TREATMENT OF MULTIDATED SCLEROSIS
CL2009000502A1|2010-03-05|Compounds derived from platinum-n-heterocyclic carbene complexes that carry an imidazole or triazole-derived ligand trans-carbene; pharmaceutical composition; and its use for the treatment of cancer.
BR112017006420A2|2017-12-19|boronic acid derivatives
GEP201706725B|2017-08-25|Compounds and compositions as inhibitors of mek
ES2525137A2|2014-12-17|Agents for treating multiple myeloma
ES2536574A1|2015-05-26|Solar tracker of central bar |
CL2015002253A1|2016-07-29|Pharmaceutical compositions for the treatment of helicobacter pylori.
CL2015002113A1|2016-01-15|Azetidinloxyphenylpyrrolidine compounds
BR112016003019A2|2017-09-12|compound, pharmaceutical composition, method for treating cancer in a subject in need thereof, and method for inhibiting a deoxycytidine kinase
CL2015003584A1|2016-06-24|New compounds for cancer treatment.
ES2633129A1|2017-09-19|Use of glycogen of marine origin for the manufacture of topical compositions to minimize biological alterations in the skin due to electromagnetic radiations emitted by electronic devices |
ES2536842T3|2015-05-29|Pharmaceutical composition for cancer treatment
ES2543850A2|2015-08-24|Use of sod metal mimetic complexes as food agents and as cosmetics |
ES2607627A1|2017-04-03|Computer with special exterior casing for its location in explosive atmospheres. |
同族专利:
公开号 | 公开日
ES2633129B1|2018-04-16|
引用文献:
公开号 | 申请日 | 公开日 | 申请人 | 专利标题
US5093109A|1990-04-04|1992-03-03|Chanel, Inc.|Cosmetic composition|
JP2003335651A|2002-05-14|2003-11-25|Noevir Co Ltd|Skin care preparation for external use|
ES2469796T3|2008-02-01|2014-06-20|Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A.|Cosmetic composition comprising glycogen for a velvety cutaneous application|
法律状态:
2018-04-16| FG2A| Definitive protection|Ref document number: 2633129 Country of ref document: ES Kind code of ref document: B1 Effective date: 20180416 |
优先权:
申请号 | 申请日 | 专利标题
ES201630326A|ES2633129B1|2016-03-18|2016-03-18|USE OF MARINE ORIGIN GLUCOGEN FOR THE MANUFACTURE OF TOPICAL COMPOSITIONS TO MINIMIZE BIOLOGICAL ALTERATIONS IN THE SKIN DUE TO ELECTROMAGNETIC RADIATIONS ISSUED BY ELECTRONIC DEVICES|ES201630326A| ES2633129B1|2016-03-18|2016-03-18|USE OF MARINE ORIGIN GLUCOGEN FOR THE MANUFACTURE OF TOPICAL COMPOSITIONS TO MINIMIZE BIOLOGICAL ALTERATIONS IN THE SKIN DUE TO ELECTROMAGNETIC RADIATIONS ISSUED BY ELECTRONIC DEVICES|
[返回顶部]